Myriad Genetics Inc (NASDAQ:MYGN)

35.76
Delayed Data
As of Mar 27
 +0.21 / +0.59%
Today’s Change
31.56
Today|||52-Week Range
42.50
+4.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Evans James S
Chief Financial Officer
Sale4/02/201476,139$40.00$3.0M-8.73%
Evans James S
Chief Financial Officer
Sale9/23/201475,864$38.08$2.9M-5.60%
Evans James S
Chief Financial Officer
Buy4/02/201476,139$30.34$2.3M-8.73%
Evans James S
Chief Financial Officer
Buy9/23/201475,864$30.12$2.3M-5.60%
Meldrum Peter D
President & Chief Executive Officer
Sale4/02/201455,000$39.57$2.2M-8.73%
Lanchbury Jerry S
Chief Scientific Officer
Sale4/02/201454,676$39.65$2.2M-8.73%
Meldrum Peter D
President & Chief Executive Officer
Buy4/02/201455,000$30.12$1.7M-8.73%
Marsh Richard M
Executive Vice President & General Counsel
Sale4/23/201431,516$39.80$1.3M-9.88%
Marsh Richard M
Executive Vice President & General Counsel
Sale4/30/201430,000$41.80$1.3M-15.28%
Lanchbury Jerry S
Chief Scientific Officer
Sale4/02/201430,000$39.80$1.2M-8.73%
Page of 9

To view my watchlist

Not a member yet?

Sign up now for a free account